A phase III randomized, open-label, controlled trial of chemotherapy and bevacizumab with or without panitumumab in the first-line treatment of patients with metastatic colorectal cancer

被引：24

作者：

Wainberg, Zev ^{[1
]}

Hecht, J. Randolph ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, GI Oncol Program, Los Angeles, CA 90095 USA

来源：

CLINICAL COLORECTAL CANCER | 2006年 / 5卷 / 05期

关键词：

epidermal growth factor receptor; 5-fluorouracil; irinotecan; leucovorin; oxaliplatin; vascular endothelial growth factor;

D O I：

10.3816/CCC.2006.n.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：363 / 367

页数：5

共 26 条

[21]

TABERNERO JM, 2004, P AN M AM SOC CLIN, V23, P248

[22] FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study [J].

Tournigand, C ;

André, T ;

Achille, E ;

Lledo, G ;

Flesh, M ;

Mery-Mignard, D ;

Quinaux, E ;

Couteau, C ;

Buyse, M ;

Ganem, G ;

Landi, B ;

Colin, P ;

Louvet, C ;

de Gramont, A .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :229-237

[23]

Weiner LM, 2005, J CLIN ONCOL, V23, p206S

[24] Untangling the ErbB signalling network [J].

Yarden, Y ;

Sliwkowski, MX .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (02) :127-137

[25]

YASUI W, 1988, CANCER RES, V48, P137

[26] Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model [J].

Yokoi, K ;

Thaker, PH ;

Yazici, S ;

Rebhun, RR ;

Nam, DH ;

He, JQ ;

Kim, SJ ;

Abbruzzese, JL ;

Hamilton, SR ;

Fidler, IJ .

CANCER RESEARCH, 2005, 65 (09) :3716-3725

← 1 2 3 →